Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 90/011168

In the image file wrapper:

Ex Parte reexam Interview Summary-Pilot Program for Waiver of Patent Owner Summary

Date of telephone interview with Henneman : 9/8/10

Patent owner agreed to waive its right to file a patent owner statement in the event a reexam is ordered

Share
New Message
Please login to post a reply